{"title":"[New drugs for small animals in 2024].","authors":"Christin Jana Kamutzki, Ilka Ute Emmerich","doi":"10.1055/a-2559-6314","DOIUrl":null,"url":null,"abstract":"<p><p>In 2024, three novel pharmaceutical agents for small animals were released on the German veterinary medicinal products market: the histamine H<sub>2</sub>-receptor antagonist ranitidine for the treatment of gastric ulcers, the alpha-2-adrenoceptor agonist tasipimidine for the relief of anxiety and the SGLT-2 inhibitor velagliflozin for the insulin-independent treatment of diabetes mellitus. No active substance was extended to other animal species. The following are new to the market for small animals: two active substances (amlodipine; fluralaner), each in a new dosage form, a new combination of active substances (neomycin sulphate + polymyxin B sulphate) and one active substance (trilostane) in two new dosage forms. There were no vaccines for small animals against new diseases and no new dosage forms. A new recombinant vaccine against Rabbit Hemorrhagic Disease Virus was approved.</p>","PeriodicalId":49434,"journal":{"name":"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere","volume":"53 2","pages":"103-110"},"PeriodicalIF":0.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2559-6314","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
In 2024, three novel pharmaceutical agents for small animals were released on the German veterinary medicinal products market: the histamine H2-receptor antagonist ranitidine for the treatment of gastric ulcers, the alpha-2-adrenoceptor agonist tasipimidine for the relief of anxiety and the SGLT-2 inhibitor velagliflozin for the insulin-independent treatment of diabetes mellitus. No active substance was extended to other animal species. The following are new to the market for small animals: two active substances (amlodipine; fluralaner), each in a new dosage form, a new combination of active substances (neomycin sulphate + polymyxin B sulphate) and one active substance (trilostane) in two new dosage forms. There were no vaccines for small animals against new diseases and no new dosage forms. A new recombinant vaccine against Rabbit Hemorrhagic Disease Virus was approved.
期刊介绍：
Die Tierärztliche Praxis wendet sich mit ihren beiden Reihen als einzige veterinärmedizinische Fachzeitschrift explizit an den Großtier- bzw. Kleintierpraktiker und garantiert damit eine zielgruppengenaue Ansprache. Für den Spezialisten bietet sie Original- oder Übersichtsartikel zu neuen Therapie- und Operationsverfahren oder den Einsatz moderner bildgebender Verfahren. Der weniger spezialisierte Tierarzt oder Berufseinsteiger findet auf seinen Berufsalltag zugeschnittene praxisbezogene Beiträge in der Fortbildungsrubrik „Aus Studium und Praxis“. Mit dem hervorgehobenen „Fazit für die Praxis“ am Ende jedes Artikels verschafft sich auch der eilige Leser einen raschen Überblick über die wichtigsten Inhalte dieser modern konzipierten Fachzeitschrift mit den vielen hochwertigen, überwiegend farbigen Abbildungen. In jedem Heft ermöglicht ein ATF-anerkannter Fortbildungsartikel den Erwerb einer ATF-Stunde (Akademie für tierärztliche Fortbildung).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
